HOME >> MEDICINE >> NEWS
Facial transplants are justified, say experts

With news of the world's first facial transplant hitting the headlines, experts in this week's BMJ debate whether the benefit of this procedure to someone with severe facial deformity outweighs the risk of long term suppression of the immune system.

One of the main areas of concern has been the risk to patients from the side effects of long term immunosuppression, say the authors. However, a patient having a facial transplant would probably require a similar level of immunosuppression to patient having a kidney transplant.

Given that one of the main justifications for kidney transplantation is improvement in quality of life, the same argument should apply to facial transplant, they write.

Concern over psychological effects is also misplaced, they say. They argue that a psychological change is not necessarily a psychological problem, and believe that the psychological impact of facial transplant can be anticipated, planned for and managed.

In terms of public fears over altered identity, the authors explain that modelling of the change in appearance, using laser scanning and photography, shows that this does not occur after facial transplantation. "Indeed, preoccupation with altered identity risks becoming too much of a distraction from the important issue of managing immunosuppression," they warn.

Although research has made the concept of facial transplant a reality, concerns about long term immunosuppression do remain. "But, instead of considering why facial transplantation cannot be justified, we may find it hard to justify why it should not be done," they conclude.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
8-Dec-2005


Page: 1

Related medicine news :

1. Facial resurfacing treats precancerous skin lesions, may help prevent skin cancer
2. Facial trauma may cause significant social and behavioral problems
3. Thymus transplants gives hope to babies with fatal immune disease
4. Outcomes for patients with hepatitis B who need liver transplants
5. Women given liver transplants outlive male recipients by around 4 years
6. How tumors respond to treatment prior to liver transplants may be useful in selecting recipients
7. National trial gives unprecedented support for steroid withdrawal in kidney transplants
8. Organ transplants just as successful in those with mental retardation
9. Liver transplants can be successful in HIV patients with Hepatitis B
10. Stem cell transplants improve recovery in animal models for stroke, cerebral palsy
11. Despite medical advances, children receiving liver transplants wait longer than a decade ago

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care ... Dallas area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards ... School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors ...
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just ... necessity inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. ... avoid bad techniques of brushing the teeth in order to prevent cavities," he said. ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine ... San Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in ... and beyond the standard of care, demonstrating leadership within the MPN community and/or a ...
(Date:12/2/2016)... Livermore, California (PRWEB) , ... December 02, 2016 ... ... business professionals, proudly announces the launch of its 60-day free trial program for ... round trip shipping make the offer a truly hassle free experience. , FlexiSpot’s ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain ... an injury, patients must find the one that works for them. When an inventor ... a machine that worked and decided to share it with others. , He developed ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 ... to hydroxyurea (HU) in Complete Hematologic Response (CHR) ... of ropeginterferon alfa-2b versus HU AOP will ... trial CONTINUATION-PV to obtain European marketing authorization in the coming ... to the FDA as it seeks approval for commercialization in ...
(Date:12/4/2016)... NEW ORLEANS , Dec. 2, 2016  Former Attorney ... Foti, Jr., Esq. , a partner at the law firm ... has commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in ... an "antitrust investigation by the Justice Department, begun about two ...
(Date:12/4/2016)... Dec. 3, 2016  Results from the Phase II ... anti-P-selectin antibody, reduced the median annual rate of sickle ... (1.63 vs 2.98, p=0.010) in patients with or without ... data are being featured in the official press briefing ... (ASH) Annual Meeting and presented during the Plenary Scientific ...
Breaking Medicine Technology:
Cached News: